Physical Training and Heart Rate Variability in COPD
Potential Effects of 6 vs 12-weeks of Physical Training on Cardiac Autonomic Function and Functional Capacity in COPD
1 other identifier
interventional
32
1 country
1
Brief Summary
To contrast the potential effects of physical exercise training program (PTP) of a 6 versus 12 weeks on cardiac autonomic modulation by linear and non-linear heart rate variability (HRV) indices and functional capacity in moderate-to-severe COPD patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2006
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 25, 2013
CompletedFirst Posted
Study publicly available on registry
June 28, 2013
CompletedResults Posted
Study results publicly available
January 10, 2014
CompletedJanuary 10, 2014
November 1, 2013
2 years
June 25, 2013
June 28, 2013
November 21, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The SD1 Index, a Nonlinear Index of Heart Rate Variability (HRV)That Represents the Parassimpatetic Activity.
Patients underwent the assessments proposed in the study on an outpatient basis before and after 6 and 12 weeks of physical exercise training program. The primary end-point measure was the SD1, a nonlinear index of HRV that represent the parasympathetic modulation
baseline (before physical exercise training program), 6 and 12 weeks after intervention
Secondary Outcomes (1)
Walking Distance on Six Minute Walking Test
Baseline (before physical exercise training program) and after 6 and 12 weeks of physical exercise training program
Study Arms (2)
Physical exercise training program
EXPERIMENTALPhysical Exercise Training Program Exercise training was conducted in three times a week, during 12 weeks at high-intensity targets. Each session consisted of a five minute warm up (walking) at 2 km/h and 30 minutes with an intensity targets set at 70% of the peak speed rate. The increase of intensity was 0.5Km/h when the patient scored less than 4 point of Borg scale (moderate to intense effort) during each session. All evaluations were done at 6th week, in order to analyze the progression of outcomes and exactly adjust the intensity of training.
No Physical Exercise Training Program
NO INTERVENTIONNo Physical Exercise Training Program
Interventions
Physical Exercise Training Program Exercise training was conducted in three times a week, during 12 weeks at high-intensity targets. Each session consisted of a five minute warm up (walking) at 2 km/h and 30 minutes with an intensity targets set at 70% of the peak speed rate. The increase of intensity was 0.5Km/h when the patient scored less than 4 point of Borg scale (moderate to intense effort) during each session. All evaluations were done at 6th week, in order to analyze the progression of outcomes and exactly adjust the intensity of training.
Eligibility Criteria
You may qualify if:
- a diagnosis of COPD according to criteria set forth by the Global Initiative for Chronic Obstructive Lung Disease (19),
- compliance with medical management,
- no change in medical management and no decompensation episodes for at least one month prior to study initiation, and
- no participation in a regular physical exercise program for at least six months prior to study initiation.
You may not qualify if:
- presence of orthopedic or neurological conditions that would preclude participation in a physical exercise program,
- a history of cardiac arrhythmias,
- a past history consistent with heart disease, diabetes mellitus, arterial hypertension and failure to comply with the research protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federal university f Sao Carlos
São Carlos, São Paulo, 13565-905, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Audrey Borghi e Silva
- Organization
- Federal university of Sao Carlos
Study Officials
- PRINCIPAL INVESTIGATOR
Audrey Borghi-Silva, PhD
Universidade Federal de Sao Carlos
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
June 25, 2013
First Posted
June 28, 2013
Study Start
May 1, 2006
Primary Completion
May 1, 2008
Study Completion
June 1, 2013
Last Updated
January 10, 2014
Results First Posted
January 10, 2014
Record last verified: 2013-11